Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice
- PMID: 14633624
- PMCID: PMC1892377
- DOI: 10.1016/S0002-9440(10)63607-3
Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice
Abstract
Apoptosis of alveolar epithelial cells (AECs) has been implicated as a key event in the pathogenesis of lung fibrosis. Recent studies demonstrated a role for the synthesis and binding of angiotensin II to receptor AT1 in the induction of AEC apoptosis by bleomycin (BLEO) and other proapoptotic stimuli. On this basis we hypothesized that BLEO-induced apoptosis and lung fibrosis in mice would be inhibited by the AT1 antagonist losartan (LOS) or by targeted deletion of the AT1 gene. Lung fibrosis was induced by intratracheal administration of BLEO (1 U/kg) to wild-type C57BL/6J mice. Co-administration of LOS abrogated BLEO-induced increases in total lung caspase 3 activity detected 6 hours after in vivo administration and reduced by 57% BLEO-induced caspase 3 activity in blood-depleted lung explants exposed to BLEO ex vivo (both P < 0.05). Co-administration of LOS in vivo reduced DNA fragmentation and immunoreactive caspase 3 (active form) in AECs, measured at 14 days after intratracheal BLEO, by 66% and 74%, respectively (both P < 0.05). LOS also inhibited the accumulation of lung hydroxyproline by 45%. The same three measures of apoptosis and lung fibrosis were reduced by 89%, 85%, and 75%, respectively (all P < 0.01), in mice with a targeted disruption of the AT1a receptor gene (C57BL/6J-Agtr1a(tm1Unc)). These data indicate an essential role for angiotensin receptor AT1a in the pathogenesis of BLEO-induced lung fibrosis in mice and suggest that AT1 receptor signaling is required for BLEO-induced apoptosis of AECs in mice as it is in rat and human AECs.
Figures
Similar articles
-
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo.Am J Physiol Lung Cell Mol Physiol. 2003 Mar;284(3):L501-7. doi: 10.1152/ajplung.00273.2002. Epub 2002 Nov 15. Am J Physiol Lung Cell Mol Physiol. 2003. PMID: 12573988
-
Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA.Curr Pharm Des. 2007;13(12):1257-68. doi: 10.2174/138161207780618867. Curr Pharm Des. 2007. PMID: 17504234
-
Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor.Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L143-51. doi: 10.1152/ajplung.2000.279.1.L143. Am J Physiol Lung Cell Mol Physiol. 2000. PMID: 10893213
-
Sphingolipids in pulmonary fibrosis.Adv Biol Regul. 2015 Jan;57:55-63. doi: 10.1016/j.jbior.2014.09.008. Epub 2014 Oct 13. Adv Biol Regul. 2015. PMID: 25446881 Free PMC article. Review.
-
Breakdown of Epithelial Barrier Integrity and Overdrive Activation of Alveolar Epithelial Cells in the Pathogenesis of Acute Respiratory Distress Syndrome and Lung Fibrosis.Biomed Res Int. 2015;2015:573210. doi: 10.1155/2015/573210. Epub 2015 Oct 7. Biomed Res Int. 2015. PMID: 26523279 Free PMC article. Review.
Cited by
-
Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.Cardiovasc Toxicol. 2021 Jun;21(6):498-503. doi: 10.1007/s12012-021-09649-y. Epub 2021 Apr 9. Cardiovasc Toxicol. 2021. PMID: 33835386 Free PMC article.
-
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice.Respir Res. 2008 May 23;9(1):43. doi: 10.1186/1465-9921-9-43. Respir Res. 2008. PMID: 18500976 Free PMC article.
-
Angiotensinogen gene transcription in pulmonary fibrosis.Int J Pept. 2012;2012:875910. doi: 10.1155/2012/875910. Epub 2012 Feb 20. Int J Pept. 2012. PMID: 22500179 Free PMC article.
-
Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.Lung. 2013 Aug;191(4):353-60. doi: 10.1007/s00408-013-9476-2. Epub 2013 May 30. Lung. 2013. PMID: 23715995 Free PMC article.
-
Proapoptotic Bid is required for pulmonary fibrosis.Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4604-9. doi: 10.1073/pnas.0507604103. Epub 2006 Mar 14. Proc Natl Acad Sci U S A. 2006. PMID: 16537427 Free PMC article.
References
-
- Selman M, King T, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136-151 - PubMed
-
- Haschek WM, Witschi HP: Pulmonary fibrosis: a possible mechanism. Toxicol Appl Pharmacol 1979, 51:475-487 - PubMed
-
- Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N: Apoptosis and expression of FAS/FAS ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997, 16:91-101 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials